SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Acquisition completion

17 Jul 2023 07:00

RNS Number : 1049G
Porvair PLC
17 July 2023
 

FOR IMMEDIATE RELEASE 17 July 2023

 

 

Porvair plc

("Porvair" or the "Group" or the "Company")

 

Acquisition completion

 

Porvair plc ("Porvair" or the "Group"), the specialist filtration, laboratory and environmental technology group, announces that on 14 July 2023 it completed its acquisition of 100% of the issued share capital of two businesses, Ratiolab GmbH and Ratiolab Kft. (together "Ratiolab"), following receipt of Hungarian regulatory approval.

 

As previously announced, Ratiolab GmbH, located outside Frankfurt, sells a wide range of laboratory consumables in Europe and the Middle East. Ratiolab Kft., located close to Budapest, manufactures laboratory consumables in an 8,000m2 facility, the freehold of which is included in the acquisition. Ratiolab has annual external revenues of around €12 million. The transaction is expected to be earnings neutral (after acquisition costs) in 2023, and earnings enhancing thereafter.

 

The Board believes Ratiolab will fit well into the Group's Laboratory division, offering a complementary product range and adding European manufacturing capabilities, injection moulding expertise, and routes to market.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Group Chief Executive

James Mills, Group Finance Director

Buchanan Communications

0207 466 5000

Charles Ryland / Simon Compton / Jack Devoy

 

Notes to Editors

Porvair is a group of specialist filtration, laboratory and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. It operates in three divisions: Aerospace & Industrial; Laboratory; and Metal Melt Quality.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQSFWFFLEDSELW
Date   Source Headline
7th Mar 20169:01 amRNSHolding(s) in Company
7th Mar 20169:00 amRNSHolding(s) in Company
1st Feb 201611:38 amRNSDirector/PDMR Shareholding
25th Jan 20167:00 amRNSFull Year Results
7th Dec 20157:00 amRNSPre-close trading update and acquisition
17th Sep 20154:15 pmRNSDirector/PDMR Shareholding
15th Sep 20157:00 amRNSTrading Update
12th Aug 20151:15 pmRNSHolding(s) in Company
12th Aug 20151:11 pmRNSHolding(s) in Company
10th Jul 201512:45 pmRNSDirector/PDMR Shareholding
29th Jun 20157:00 amRNSInterim Results
23rd Jun 20155:00 pmRNSHolding(s) in Company
2nd Jun 20157:00 amRNSTrading Update
29th May 20155:31 pmRNSTotal Voting Rights
30th Apr 20157:02 amRNSDirector declaration
14th Apr 20152:55 pmRNSAGM resolutions
14th Apr 20157:00 amRNSAGM Statement and Trading Update
24th Mar 20152:25 pmRNSPosting of Accounts
11th Mar 20157:00 amRNSHolding(s) in Company
5th Feb 20157:00 amRNSHolding(s) in Company
30th Jan 20154:03 pmRNSEx-Dividend Date
27th Jan 201512:11 pmRNSDirectors' Shareholdings and Issue of Equity
26th Jan 201512:30 pmRNSDirector Declaration
26th Jan 20157:00 amRNSSignificant Contract Wins
26th Jan 20157:00 amRNSFull Year Results
4th Dec 20147:00 amRNSSignificant Contract Win
1st Dec 20147:00 amRNSPre-close trading update
5th Nov 20147:00 amRNSDirector/PDMR Shareholding
16th Sep 20147:00 amRNSInterim Management Statement
23rd Jun 20147:00 amRNSInterim Results
5th Jun 20148:50 amRNSTotal Voting Rights
3rd Jun 20147:00 amRNSTrading Update
23rd Apr 201411:39 amRNSDirector Declaration
8th Apr 20144:20 pmRNSAGM resolutions
8th Apr 20147:00 amRNSAGM Statement and IMS
25th Feb 20147:00 amRNSAppointment of Non-Executive Director
3rd Feb 201410:08 amRNSDirector/PDMR Shareholding
27th Jan 20147:00 amRNSPreliminary Results
16th Jan 20144:07 pmRNSBlocklisting Application
4th Dec 20137:00 amRNSPre-close trading update
29th Nov 20134:02 pmRNSTotal Voting Rights
26th Sep 20137:00 amRNSAcquisition and Licensing agreement
25th Sep 20134:10 pmRNSDirector/PDMR Shareholding
17th Sep 20137:00 amRNSInterim Management Statement
7th Aug 20134:32 pmRNSHolding(s) in Company
6th Aug 20137:00 amRNSContract extension
15th Jul 201311:17 amRNSHolding(s) in Company
9th Jul 20135:13 pmRNSHolding(s) in Company
28th Jun 201312:25 pmRNSHolding(s) in Company
28th Jun 201312:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.